Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Haikang Zhao
NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24
Cancer Biotherapy and Radiopharmaceuticals
Nuclear Medicine
Radiology
Pharmacology
Cancer Research
Oncology
Imaging
Medicine
Related publications
Long Non-Coding RNA NCK1-AS1 Promotes the Tumorigenesis of Glioma Through Sponging microRNA-138-2-3p and Activating the TRIM24/Wnt/β-catenin Axis
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Silencing LDHA Inhibits Proliferation, Induces Apoptosis and Increases Chemosensitivity to Temozolomide in Glioma Cells
Oncology Letters
Cancer Research
Oncology
Knockdown of Long Non-Coding RNA XIST Increases Blood–tumor Barrier Permeability and Inhibits Glioma Angiogenesis by Targeting miR-137
Oncogenesis
Cancer Research
Molecular Biology
Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined With Poly (ADP-Ribose) Polymerase Inhibitor
Molecular Pharmacology
Molecular Medicine
Pharmacology
H19 Induced by Oxidative Stress Confers Temozolomide Resistance in Human Glioma Cells via Activating NF-κB Signaling
OncoTargets and Therapy
Oncology
Pharmacology
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide
Molecular Cancer Therapeutics
Cancer Research
Oncology
HNF1A-AS1 Regulates Cell Migration, Invasion and Glycolysis via Modulating miR-124/MYO6 in Colorectal Cancer Cells
OncoTargets and Therapy
Oncology
Pharmacology
lncRNA CCAT2 Enhanced Resistance of Glioma Cells Against Chemodrugs by Disturbing the Normal Function of miR-424
OncoTargets and Therapy
Oncology
Pharmacology
LncRNA ZEB2-AS1 Regulates the Drug Resistance of Acute Myeloid Leukemia via the miR-142-3p/INPP4B Axis
RSC Advances
Chemistry
Chemical Engineering
